CXCR7 activation by CXCL12 was shown to bias its signalling to β-arrestin, which promoted EMT and metastasis through induction of YAP1 nuclear transportation, resulting in the downregulation of mi-RNAs and promoting expression of DCLK1, a tumour stem cell marker [237]. Here, CXCL12 is linked to neoplasm.